The most common genetic event in ER+ breast cancer is mutation of PIK3CA, the gene encoding the p110α catalytic subunit of phosphoinositide 3-kinase alpha (PI3Kα), which occurs in up to 40% of ER+ breast cancers [5,6]. Here, PIK3CA is linked to breast cancer.